Forecast & Rating4 analysts currently cover InnoCare Pharma, of which 3 give a positive rating. The average price target is ¥30.72, about 3.7% downside from the current price of ¥31.90. Coverage is limited, so the data is for reference only. Data as of May 4, 2026; this does not constitute investment advice.
May 1, 2026Price forecast
¥30.72-3.69%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met73.0%
Stock price$31.90
Avg. target$31.0
High target$47
Low target$20
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.